A phase I study of OSI-7904L in combination with oxaliplatin in patients with advanced colo-rectal cancer
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2013
At a glance
- Drugs OVI 237 (Primary) ; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 11 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Aug 2005 New trial record.